Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126532201 | 12653220 | 1 | I | 2015 | 20150827 | 20160815 | 20160815 | PER | US-ENDO PHARMACEUTICALS INC.-2015-002606 | ENDO | 0.00 | F | Y | 54.48000 | KG | 20160815 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126532201 | 12653220 | 1 | PS | LACTULOSE ORAL SOLUTION | LACTULOSE | 1 | Unknown | Y | UNKNOWN | 75993 | SOLUTION | ||||||||
| 126532201 | 12653220 | 2 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 126532201 | 12653220 | 3 | C | DILTIAZEM. | DILTIAZEM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126532201 | 12653220 | 1 | Constipation |
| 126532201 | 12653220 | 2 | Thyroid disorder |
| 126532201 | 12653220 | 3 | Hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126532201 | 12653220 | Constipation | |
| 126532201 | 12653220 | Drug ineffective | |
| 126532201 | 12653220 | Rash generalised |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126532201 | 12653220 | 1 | 201508 | 201508 | 0 |